A Revolutionizing Time in Immuno-Oncology for Bladder Cancer – Neal Shore
There has been a limited number of new therapeutics, particularly in the area of patients who would benefit from advanced systemic bladder cancer treatments. Dr. Neal Shore reviews some pioneering work from the past such as MVAC and gemcitabine platinum based combinations but he notes those treatments are where things were left for many many years. The development of immuno-oncology is revolutionizing how physicians should be thinking about bladder and renal cancer treatments.
